BANB:SWX
BACHEM HOLDING AG
၆၆.၀၅ CHF
arrow_downward
-၀.၄၅%(-၀.၃၀) 1D
ဇွန် ၁၂, GMT+၂ ၁၇:၃၁:၀၀ · CHF
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BANB...
Open
၆၇.၄၅ CHF
High
၆၇.၆၅ CHF
Low
၆၅.၁၅ CHF
Mkt. cap
၄၉၅.၃၈ ဋေ
Avg. vol.
၁.၅၃ သိန်း
Volume
၀.၀၀
Dividend
၁.၃၆%
Quarterly dividend
၀.၂၂ CHF
Ex-dividend date
၂၀၂၆ မေ ၄
P/E ratio
၃၃.၂၈
52-wk high
၈၃.၂၅ CHF
52-wk low
၄၈.၅၂ CHF
EPS
၁.၉၈ CHF
Shares outstanding
၇.၅၀ ကုဋေ
No. of employees
၂ ထောင်
Open
၆၇.၄၅ CHF
High
၆၇.၆၅ CHF
Low
၆၅.၁၅ CHF
Mkt. cap
၄၉၅.၃၈ ဋေ
Avg. vol.
၁.၅၃ သိန်း
Volume
၀.၀၀
Dividend
၁.၃၆%
Quarterly dividend
၀.၂၂ CHF
Ex-dividend date
၂၀၂၆ မေ ၄
P/E ratio
၃၃.၂၈
52-wk high
၈၃.၂၅ CHF
52-wk low
၄၈.၅၂ CHF
EPS
၁.၉၈ CHF
Shares outstanding
၇.၅၀ ကုဋေ
No. of employees
၂ ထောင်
Analyst outlook
Analyst Ratings
Based on 5 analysts giving stock ratings to BANB in the past 3 months
Strong Buy
Buy
4
Hold
1
Sell
0
12 month forecast
Based on 5 Wall Street analysts offering 12 month price targets for BANB in the last 3 months.
Highest
Current ၆၆.၀၅ CHF
၁၁၀.၀၀ CHF (+၆၆.၅၄%)
Average
၈၅.၂၀ CHF (+၂၈.၉၉%)
Lowest
၇၀.၀၀ CHF (+၅.၉၈%)
News stories
From sources across the web
Investor's Business Daily
·
ပြီးခဲ့သည့် ၂ နာရီ
Futures: Iran Deal In Focus; Five Stocks In Buy Areas
TheStreet
·
ပြီးခဲ့သည့် ၂၂ မိနစ်
Why Rocket Lab stock tumbled on Nasdaq-100 news
TechStock²
·
ပြီးခဲ့သည့် ၁ နာရီ
S&P 500 Looks to Fed Meeting, Retail Reports for Direction
Yahoo Finance
·
ပြီးခဲ့သည့် ၂ နာရီ
Gold vs. the S&P 500: With Inflation at a 3-Year High, Which Does History Say Wins?
Profile
Bachem Holding AG is a Swiss biotechnology company specializing in the development and manufacture of peptides and complex organic molecules for use as active pharmaceutical ingredients. The company focuses on peptide-based therapeutics, including large-scale commercial production and process development for pharmaceutical applications. It was founded in 1971 and is a subsidiary of Ingro Finanz AG.
The head office is in Bubendorf in the canton of Basel-Landschaft. Bachem operates production facilities in Vionnaz, Vista and Torrance, and St Helens, as well as a sales and distribution site in Tokyo.
Bachem is one of the largest manufacturers of peptide-based APIs globally, supplying pharmaceutical and biotechnology companies with products used in both clinical development and commercial therapies.
In recent years, the company has expanded its manufacturing capacity, including new large-scale production facilities in Switzerland and the United States.
At the end of 2025, the company employed 2,511 people, reported revenue of CHF 695.1 million, and net income of CHF 148.8 million. Wikipedia
About BACHEM HOLDING AG
AI content may include mistakes. Learn more